Gufic Biosciences Limited (BOM:509079)
India
· Delayed Price · Currency is INR 373.50
+3.50 (0.95%)
At close: Jun 10, 2025
Gufic Biosciences Revenue
In the fiscal year ending March 31, 2025, Gufic Biosciences had annual revenue of 8.20B INR with 1.63% growth. Gufic Biosciences had revenue of 2.05B in the quarter ending March 31, 2025, with 5.14% growth.
Revenue
8.20B
Revenue Growth
+1.63%
P/S Ratio
4.53
Revenue / Employee
5.50M
Employees
1,491
Market Cap
37.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.20B | 131.40M | 1.63% |
| Mar 31, 2024 | 8.07B | 1.16B | 16.80% |
| Mar 31, 2023 | 6.91B | -885.35M | -11.36% |
| Mar 31, 2022 | 7.79B | 2.91B | 59.76% |
| Mar 31, 2021 | 4.88B | 1.09B | 28.74% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |
Gufic Biosciences News
- 4 months ago - Gufic Biosciences Ltd (BOM:509079) Q3 2025 Earnings Call Highlights: Navigating Profitability ... - GuruFocus
- 4 months ago - Q3 2025 Gufic Biosciences Ltd Earnings Call Transcript - GuruFocus